Nudges for Smoking Cessation in Mental Illness
(ISRAISE Trial)

Recruiting in Palo Alto (17 mi)

Overseen byLi-Shiun Chen, M.D., MPH, ScD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Washington University School of Medicine

No Placebo Group

Trial Summary

What is the purpose of this trial?This is a pilot trial to examine the feasibility and preliminary effect of a multilevel intervention 'Nudges to Quit' on smoking cessation in patients with serious mental illness who smoke in a community mental health center (CMHC). "Nudges to Quit" is a multilevel intervention to increate engagement of patient, case worker, and pharmacist with tobacco treatment. The pilot trial is to generate the needed evidence for designing a future large trial to evaluate the effect of 'Nudges to Quit' as a multilevel intervention to increase tobacco treatment and reduce tobacco use among patients with serious mental illness.

Eligibility Criteria

This trial is for adults over 18 who are patients at a participating clinic, speak and understand English, and currently smoke more than five cigarettes per day. It's not for those actively using or prescribed smoking cessation medication in the past month.

Inclusion Criteria

Patient of participating clinic

Current smoker, >5 cigarettes per day

I am 18 years old or older.

+1 more

Exclusion Criteria

Active use or receipt of tobacco treatment (medication or counseling) within the past 30 days

Participant Groups

'Nudges to Quit' is being tested as a way to help people with serious mental illness quit smoking by increasing engagement between patients, case workers, and pharmacists. This pilot study will inform a larger future trial.

2Treatment groups

Experimental Treatment

Active Control

Group I: "Nudges to Quit"Experimental Treatment1 Intervention

Patients will receive a multilevel intervention that includes reminders to care team to increase tobacco treatment engagement.

Group II: Usual CareActive Control1 Intervention

Patients will receive general brief advice about smoking cessation at patient tobacco treatment needs assessment then receive the intervention at 3 months.